|
Index of reports
> All cases (103)
Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes all cases.
Reports 1 - 25 of 103 Next >>
Adverse event in receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-24
Patient:
Adverse reactions / side effects: Abdominal Pain, Oral Intake Reduced, Weight Decreased, Dysphagia, Pneumonia Aspiration, Incorrect Dose Administered, Muscular Weakness, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: 1370 units, single
Indication: Cerebral Palsy
Start date: 2007-09-18
End date: 2007-09-18
Botox
Indication: Muscle Spasticity
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-24
Patient: male
Adverse reactions / side effects: Botulism
Suspect drug(s):
Botox
Indication: Muscle Spasticity
Botox
Indication: Cerebral Palsy
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Japan on 2007-10-24
Patient: male
Adverse reactions / side effects: Nephrolithiasis, Urinary Tract Infection, Benign Prostatic Hyperplasia
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: unk, single
Indication: Drug USE FOR Unknown Indication
Start date: 2007-06-26
End date: 2007-06-26
Botox
Dosage: unk, single
Indication: Drug USE FOR Unknown Indication
Start date: 2007-06-26
End date: 2007-06-26
Botox
Dosage: unk, single
Indication: Drug USE FOR Unknown Indication
Start date: 2007-09-18
End date: 2007-09-18
Adverse event in 24 year old female receiving Botox (Botulinum Toxin Type A)
Reported by a individual with unspecified qualification from United States on 2007-10-23
Patient: 24 year old female
Adverse reactions / side effects: Botulism
Adverse event resulted in: life threatening event
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-22
Patient:
Adverse reactions / side effects: Botulism
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-22
Patient: female, weighing 11.8 kg (26.0 pounds)
Adverse reactions / side effects: Overdose, Botulism
Suspect drug(s):
Botox
Dosage: 400 units, single
Indication: Muscle Spasticity
Botox
Indication: Cerebral Palsy
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-22
Patient: female
Adverse reactions / side effects: Stridor, Vocal Cord Disorder
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Other drugs received by patient: Succinylcholine Chloride; Oxygen
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-19
Patient: female
Adverse reactions / side effects: Endocarditis Bacterial, Bacteraemia, Sepsis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from United States on 2007-10-19
Patient: female
Adverse reactions / side effects: Facial Paresis, Dysphagia, Vomiting, Aspiration, Dehydration, Urinary Tract Infection, Salivary Hypersecretion, Constipation
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: 25 units, single
Indication: Drooling
Start date: 2007-09-12
End date: 2007-09-12
Botox
Indication: Mucopolysaccharidosis IV
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from Denmark on 2007-10-18
Patient: male
Adverse reactions / side effects: Myalgia, Incorrect Route of Drug Administration, Activities of Daily Living Impaired, Muscular Weakness
Adverse event resulted in: disablity
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Other drugs received by patient: Lyrica
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Finland on 2007-10-18
Patient: female
Adverse reactions / side effects: Dysphagia
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a health professional (non-physician/pharmacist) from Australia on 2007-10-18
Patient: female
Adverse reactions / side effects: Vision Blurred, Musculoskeletal Stiffness, Hyperhidrosis
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-17
Patient: female
Adverse reactions / side effects: Sepsis, Endocarditis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from Norway on 2007-10-12
Patient: female
Adverse reactions / side effects: Balance Disorder, Pain, Paralysis, Dizziness
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-12
Patient: female
Adverse reactions / side effects: Urinary Tract Infection, Mediastinitis, Chest Pain, Pharyngolaryngeal Pain, Pyrexia, Oesophageal Ulcer
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Other drugs received by patient: Pethidin; Midazolam HCL; Glyburide; Insulin
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-11
Patient: male, weighing 86.2 kg (189.6 pounds)
Adverse reactions / side effects: Blood Pressure Increased, Dysphagia, Dyspnoea, Pain in Extremity, Headache, Muscle Spasticity, Mantle Cell Lymphoma, Anxiety, Dysarthria, Malaise, Fatigue, Dysphonia, Neck Pain, Dizziness
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: 400 units, single
Indication: Pain
Start date: 2007-02-06
End date: 2007-02-06
Botox
Indication: Dystonia
Other drugs received by patient: Celebrex; Tylenol W / Codeine NO. 3
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from United States on 2007-10-10
Patient: female
Adverse reactions / side effects: Osteonecrosis
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-10
Patient: male, weighing 88.0 kg (193.6 pounds)
Adverse reactions / side effects: Cellulitis, Pain, Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: unk, single
Indication: Muscular Weakness
Start date: 2007-02-01
End date: 2007-02-01
Temozolomide
Dosage: 145 mg, qd
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2006-12-01
End date: 2007-01-18
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Spain on 2007-10-08
Patient: female
Adverse reactions / side effects: Dizziness
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a pharmacist from Japan on 2007-10-08
Patient: female
Adverse reactions / side effects: Pyrexia, Loss of Consciousness
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a physician from Japan on 2007-10-06
Patient: female
Adverse reactions / side effects: Back Pain, Diarrhoea, Injection Site Pain, Meningitis Viral, Skin Tightness
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in male receiving Botox (Botulinum Toxin Type A)
Reported by a consumer/non-health professional from Norway on 2007-10-05
Patient: male
Adverse reactions / side effects: Dysphagia, Muscular Weakness
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Other drugs received by patient: Enalapril Maleate; Enanton Depot SET; Allopur; Hydrochlorothiazide
Adverse event in 61 year old male receiving Botox (Botulinum Toxin Type A)
Reported by a physician from United States on 2007-10-05
Patient: 61 year old male, weighing 88.0 kg (193.6 pounds)
Adverse reactions / side effects: Blood Urea Increased, Cellulitis, Diabetes Mellitus, Hyperglycaemia, Lymphopenia, Pain, General Physical Health Deterioration, Hyponatraemia, Insomnia, NO Therapeutic Response, Blood Sodium Increased, Hypoalbuminaemia, Depression, Peripheral Motor Neuropathy, Myopathy Steroid
Adverse event resulted in: hospitalization
Suspect drug(s):
Botox
Dosage: once
Indication: Muscular Weakness
Start date: 2007-02-01
End date: 2007-02-01
Temozolomide
Dosage: po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2006-12-01
End date: 2007-01-18
Adverse event in 42 year old male receiving Botox (Botulinum Toxin Type A)
Reported by a individual with unspecified qualification from United States on 2007-10-03
Patient: 42 year old male, weighing 85.3 kg (187.6 pounds)
Adverse reactions / side effects: Weight Decreased, Hyperacusis, Tinnitus, Impaired Work Ability, Musculoskeletal Discomfort, Headache, Sensation of Pressure, Stress, Discomfort, Meniere's Disease, Anxiety, DRY Mouth, Depression, DRY Eye
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Adverse event in female receiving Botox (Botulinum Toxin Type A)
Reported by a pharmacist from Japan on 2007-07-31
Patient: female
Adverse reactions / side effects: Pyrexia, Loss of Consciousness
Suspect drug(s):
Botox (Botulinum Toxin Type A)
Page 1 Next >>
|
